Tag
The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.
Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused to review Moderna’s new mRNA flu vaccine. That could set vaccine research and development back for years.
Retail pharmacists deal with understaffing and burnout as their job responsibilities expand beyond dispensing medication.
The pandemic led to an explosion of interest in and funding of biotech. That continues even as many sectors slow and recession fears grow.
The anti-COVID shot passes muster with FDA advisers. It was developed with traditional technology, which might boost trust.
The aim: Making access to the company’s COVID vaccine more equitable.
Strains on ICUs across the province are behind the provincial government’s decision.
Delta could slow the economy in two main ways: Governments could restrict consumers — again — or consumers could restrict themselves.
“They are on the front lines of the food production industry in this country,” said Patrick Smith, who runs Loftus Ranches.
The CEO of the Serum Institute of India said American raw materials are running out due to Biden administration policy.
